Results 1 to 10 of about 24,013 (236)

Renal Involvement in Antiphospholipid Syndrome

open access: yesFrontiers in Immunology, 2018
Antiphospholipid syndrome is a complex autoimmune disease, characterized by the presence of vascular thrombosis, obstetric, hematologic, cutaneous, and cardiac manifestations. Renal disease in patients with antiphospholipid syndrome was not recognized in
Alonso Turrent-Carriles   +2 more
doaj   +3 more sources

Antiphospholipid Syndrome [PDF]

open access: yesTranslational Research, 2008
Antiphospholipid syndrome is one of the more common acquired causes of hypercoagulability. Its major presentations are thrombotic (arterial, venous, or microvascular) and pregnancy morbidity (miscarriages, late intrauterine fetal demise, and severe pre-eclampsia).
Cervera, Ricard, Espinosa, Gerard
openaire   +6 more sources

Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature

open access: yesBrain Sciences, 2021
(1) Background: The Antiphospholipid Syndrome (APS) is a systemic autoimmune disorder characterized by arterial and/or venous thrombosis, pregnancy morbidity and raised titers of antiphospholipid antibodies.
Alba Jerez-Lienas   +9 more
doaj   +1 more source

Antiphospholipid Syndrome [PDF]

open access: yesBest Practice & Research Clinical Rheumatology, 2016
Antiphospholipid syndrome (APS) is an autoimmune condition characterized by the occurrence of thrombosis (arterial and/or venous), often multiple, and/or pregnancy morbidity. Thrombosis is one of the major disease mechanisms, mainly caused by activating endothelial cells, monocytes, and platelets.
Khamashta, M.   +3 more
openaire   +5 more sources

Direct-acting oral anticoagulants in antiphospholipid syndrome

open access: yesНаучно-практическая ревматология, 2021
Antiphospholipid syndrome is an acquired autoimmune thrombophilia characterized by the development of recurrent vascular thrombosis of any caliber and type or obstetric pathology and the mandatory identification of persistently positive antiphospholipid ...
T. M. Reshetnyak, K. S. Nurbaeva
doaj   +1 more source

Consequences of antiphospholipid syndrome in pregnancy - A review [PDF]

open access: yesRomanian Journal of Rheumatology, 2023
Background and objectives. Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence of antiphospholipid antibodies (aPL) in the blood.
Astrit M. Gash
doaj   +1 more source

Antiphospholipid syndrome and pulmonary involvement

open access: yesВісник медичних і біологічних досліджень, 2022
Summary. Antiphospholipid syndrome is characteri­zed by venous and arterial thrombosis and severe complications that frequently lead to deaths. The production of antiphospholipid antibodies (anticardiolipin antibodies, antibodies to β2-glycoprotein 1
N.Ya. Mehno, O.Z. Yaremchuk
doaj   +1 more source

Type 1 diabetes recurrence after SARS‐CoV‐2 infection in a subject with pancreas transplantation

open access: yesEndocrinology, Diabetes &Metabolism, Volume 6, Issue 1, January 2023., 2023
During COVID‐19 pandemic, several studies have demonstrated a strong link between SARS‐CoV2 infection and diabetes mellitus. Little is known about the effects of SARS‐CoV‐2 infection on glycaemic control in pancreas transplant patients. Abstract Background During COVID‐19 pandemic, several studies have demonstrated a strong link between SARS‐CoV‐2 ...
Valentina Popolla   +4 more
wiley   +1 more source

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches

open access: yesEuropean Journal of Immunology, Volume 53, Issue 1, January 2023., 2023
B lineage cells have been identified as therapeutic targets in autoimmune diseases. In the current review article, we provide an overview of novel strategies to target B lineage cells in autoimmune diseases, with a focus on inflammatory rheumatic diseases.
Ana Merino‐Vico   +3 more
wiley   +1 more source

First‐trimester screening for pre‐eclampsia and small for gestational age: A comparison of the gaussian and Fetal Medicine Foundation algorithms

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 160, Issue 1, Page 150-160, January 2023., 2023
Abstract Objective Pre‐eclampsia (PE) and small for gestational age (SGA) can be predicted from the first trimester. The most widely used algorithm worldwide is the Fetal Medicine Foundation (FMF) algorithm. The recently described Gaussian algorithm has reported excellent results although it is unlikely to be externally validated.
Berta Serrano   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy